Two quick zaps: new radiation approach aims to cut prostate cancer treatment time

NCT ID NCT05864196

Recruiting now Disease control Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial is testing a new way to deliver radiation for low-to-intermediate risk prostate cancer. Instead of many sessions, it uses just two high-dose treatments, with an extra boost to the main tumor. The goal is to see if this approach is safe and feasible for about 80 men aged 18 and older.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

NYCyberKnife at Perlmutter Cancer Center
RECRUITING

New York, New York, 10016, United States
NYU Langone Hospital - Long Island
RECRUITING

Mineola, New York, 11501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.